Lunit Inc. (KOSDAQ: 328130)

South Korea flag South Korea · Delayed Price · Currency is KRW
42,100
+350 (0.84%)
Sep 11, 2024, 2:59 PM KST
-83.33%
Market Cap 1.23T
Revenue (ttm) 26.03B
Net Income (ttm) -22.06B
Shares Out 28.87M
EPS (ttm) -1,952.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 914,009
Open 42,100
Previous Close 41,750
Day's Range 41,350 - 44,050
52-Week Range 31,000 - 279,500
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About Lunit

Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea. [Read more]

Industry Prepackaged Software
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 328130
Full Company Profile

Financial Performance

In 2023, Lunit's revenue was 25.08 billion, an increase of 80.88% compared to the previous year's 13.87 billion. Losses were -36.80 billion, -5.93% less than in 2022.

Financial Statements

News

There is no news available yet.